Your browser doesn't support javascript.
loading
Four-years retention rate of golimumab administered after discontinuation of non-TNF inhibitors in patients with inflammatory rheumatic diseases.
Pombo-Suárez, Manuel; Seoane-Mato, Daniel; Díaz-González, Federico; Sánchez-Alonso, Fernando; Sánchez-Jareño, Marta; Cea-Calvo, Luis; Castrejón, Isabel.
Affiliation
  • Pombo-Suárez M; Department of Rheumatology, Hospital Universitario de Santiago de Compostela, Rúa da Choupana, S/N, 15706, Santiago de Compostela, A Coruña, Spain. mpombosuarez@gmail.com.
  • Seoane-Mato D; Clinical Research Unit, Spanish Society of Rheumatology (SER), Madrid, Spain.
  • Díaz-González F; Department of Rheumatology, Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain.
  • Sánchez-Alonso F; Department of Internal Medicine, Dermatology and Psychiatry, Universidad de La Laguna, Santa Cruz de Tenerife, Spain.
  • Sánchez-Jareño M; Instituto de Tecnologías Biomédicas (ITB), Universidad de La Laguna, Santa Cruz de Tenerife, Spain.
  • Cea-Calvo L; Clinical Research Unit, Spanish Society of Rheumatology (SER), Madrid, Spain.
  • Castrejón I; Medical Affairs, MSD Spain, Madrid, Spain.
Adv Rheumatol ; 63(1): 25, 2023 06 07.
Article in En | MEDLINE | ID: mdl-37287051
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Arthritis, Rheumatoid / Rheumatic Fever / Arthritis, Psoriatic / Antirheumatic Agents Type of study: Observational_studies Limits: Adult / Humans Language: En Year: 2023 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Arthritis, Rheumatoid / Rheumatic Fever / Arthritis, Psoriatic / Antirheumatic Agents Type of study: Observational_studies Limits: Adult / Humans Language: En Year: 2023 Type: Article